[go: up one dir, main page]

PL4404916T3 - Ulepszona kompozycja farmaceutyczna do stosowania donosowego, jej wytwarzanie i stosowanie - Google Patents

Ulepszona kompozycja farmaceutyczna do stosowania donosowego, jej wytwarzanie i stosowanie

Info

Publication number
PL4404916T3
PL4404916T3 PL22790469.5T PL22790469T PL4404916T3 PL 4404916 T3 PL4404916 T3 PL 4404916T3 PL 22790469 T PL22790469 T PL 22790469T PL 4404916 T3 PL4404916 T3 PL 4404916T3
Authority
PL
Poland
Prior art keywords
preparation
pharmaceutical composition
nasal
improved pharmaceutical
improved
Prior art date
Application number
PL22790469.5T
Other languages
English (en)
Inventor
Zdravka Knezevic
Karina VUKELIC
Laura SIMIC
Nina POPOVIC
Vesna SARSON
Original Assignee
Jadran - Galenski Laboratorij D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jadran - Galenski Laboratorij D.D. filed Critical Jadran - Galenski Laboratorij D.D.
Publication of PL4404916T3 publication Critical patent/PL4404916T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL22790469.5T 2021-09-22 2022-09-16 Ulepszona kompozycja farmaceutyczna do stosowania donosowego, jej wytwarzanie i stosowanie PL4404916T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HRP20211486 2021-09-22
PCT/EP2022/075786 WO2023046590A1 (en) 2021-09-22 2022-09-16 An improved pharmaceutical composition for nasal use, preparation, and use thereof

Publications (1)

Publication Number Publication Date
PL4404916T3 true PL4404916T3 (pl) 2025-12-08

Family

ID=83898344

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22790469.5T PL4404916T3 (pl) 2021-09-22 2022-09-16 Ulepszona kompozycja farmaceutyczna do stosowania donosowego, jej wytwarzanie i stosowanie

Country Status (4)

Country Link
EP (1) EP4404916B1 (pl)
ES (1) ES3039833T3 (pl)
PL (1) PL4404916T3 (pl)
WO (1) WO2023046590A1 (pl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549421C2 (de) 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
WO2000078297A2 (de) 1999-06-22 2000-12-28 Boehringer Ingelheim International Gmbh Stabile xylometazolin- und oxymetazolinlösung
DE10064219B9 (de) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung
DE10337186A1 (de) 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
DE20318634U1 (de) 2003-11-13 2004-02-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
DE102012005452A1 (de) * 2011-12-30 2013-07-04 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die nasale Applikation mit verbesserter Stabilität
CN103705463A (zh) * 2014-01-14 2014-04-09 中国药科大学 一种鼻用温度敏感型水凝胶喷雾
DE202017104738U1 (de) 2017-07-31 2018-08-01 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
ES2972897T3 (es) * 2017-08-10 2024-06-17 Elixir Ilac Arastirma Ve Gelistirme A S Composiciones descongestionantes nasales que comprenden mentol, dexpantenol e hialuronato de sodio

Also Published As

Publication number Publication date
EP4404916C0 (en) 2025-08-06
ES3039833T3 (en) 2025-10-24
EP4404916B1 (en) 2025-08-06
WO2023046590A1 (en) 2023-03-30
EP4404916A1 (en) 2024-07-31

Similar Documents

Publication Publication Date Title
IL289513A (en) A pharmaceutical preparation for administration through the nose
SG11202105850YA (en) Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof
MX2021004110A (es) Composiciones farmaceuticas que comprenden n-(3,5- dimetoxifenil)-n'-(1-metiletil)-n-[3-(1-metil-1h- pirazol-4-il)quinoxalin-6-il]etano-1,2-diamina.
WO2012074231A3 (ko) 모메타손 푸로에이트 및 아젤라스틴 염산염을 포함하는 비내 투여용 약학 조성물
IL287905A (en) A pharmaceutical preparation containing brexanolone, gnaxolone or zoranolone and its use
IL276244A (en) A pharmaceutical preparation for the eyes, a method for its preparation and its application
PL3786167T3 (pl) Diarylowy związek makrocykliczny i kompozycja farmaceutyczna oraz ich zastosowanie
SG11202107848TA (en) Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereof
EP4053154A4 (en) KERATIN BD-10, METHOD FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITION THEREOF, AND ITS USE
ZA202105586B (en) Pharmaceutical delivery compositions and uses thereof
EP3858846A4 (en) NUCLEIC ACID NANO-CARRIER MEDICINE, METHOD FOR PREPARING IT, PHARMACEUTICAL COMPOSITION THEREOF, AND CORRESPONDING USE
EP4223759A4 (en) PYRAZOLOPYRIDAZINONE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND ITS USE
IL285277A (en) History of imidazoquinolines and their use
IL285421B2 (en) History of indazolyl-isoxazoles, their preparation and pharmaceutical preparations containing them
IL289943A (en) Medicinal and/or pharmaceutical compositions for insertion into a blister, preparation and uses
GB2590189B (en) Lycorine derivative, and pharmaceutical composition and use thereof
AU2021413439A9 (en) Pharmaceutical composition for inhalation
IL210975A (en) Annapomapungin History, Pharmaceuticals Containing Them and Their Use in Preparing Medicines to Treat Fungal Infections
GB202415076D0 (en) 5-pyridine-1h-indazole compound, pharmaceutical composition, and use
EP4053155A4 (en) KERATIN BD-4, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
PL4404916T3 (pl) Ulepszona kompozycja farmaceutyczna do stosowania donosowego, jej wytwarzanie i stosowanie
CA3261961A1 (en) Lipoligourates, pharmaceutical composition and lipooligourates intended for use as a medicinal product
PT3650024T (pt) Composição farmacêutica para administração nasal compreendendo rifampicinas para tratar demência
GB202004832D0 (en) Therapeutic agaents, pharmaceutical compositions, and associated biomarkers
IL284587A (en) A pharmaceutical compound containing an antibody, a device containing it, and its use